ANS

:   1‐anilino‐8‐naphthalenesulfonate

CD

:   Crohn's disease

CFU

:   colony‐forming units

CL

:   chemiluminescence

DMC

:   4‐dimethylaminochalcone

DMEM

:   Dulbecco's modified Eagle's medium

DW

:   dry weight

FBS

:   fetal bovine serum

IBD

:   inflammatory bowel disease

KRB

:   Krebs--Ringer bicarbonate

OD

:   optical density

PBS

:   phosphate‐buffered saline

PMA

:   phorbol 12‐myristate 13‐acetate

RHS

:   reactive halogen species

ROS

:   reactive oxygen species

Progression of inflammatory bowel diseases (IBD) is associated with alteration in gut microbiota. Dysbiosis often observed in CD patients is associated with an expansion of *Escherichia coli* capable of various adaptive reactions [1](#feb412796-bib-0001){ref-type="ref"}, [2](#feb412796-bib-0002){ref-type="ref"}, [3](#feb412796-bib-0003){ref-type="ref"}. One of these reactions is surviving the attack of human immune system. Thus, antibodies to *E. coli* were found in biopsy samples from ulcer, erosion, and granuloma of patients with Crohn's disease, suggesting the presence of bacteria at the very spot of acute inflammation [4](#feb412796-bib-0004){ref-type="ref"}.

It is hard to estimate whether it would be more profitable for bacteria to avoid neutrophil stimulation, or to provoke it. On the one hand, negative correlation between neutrophil‐stimulating capacity and virulence was shown for uropathogenic *E. coli* [5](#feb412796-bib-0005){ref-type="ref"}. At the same time, ROS/RHS produced by activated neutrophils at the site of inflammation can enhance damage of gut wall [6](#feb412796-bib-0006){ref-type="ref"}, [7](#feb412796-bib-0007){ref-type="ref"}, [8](#feb412796-bib-0008){ref-type="ref"} facilitating further bacterial expansion [3](#feb412796-bib-0003){ref-type="ref"}.

Upon activation, neutrophils produce reactive oxygen (^•^O~2~ˉ, H~2~O~2~, ^•^OH, etc.) and halogen (HOCl, HOBr, etc.) species (ROS/RHS), which can be detected by chemiluminescence (CL) [9](#feb412796-bib-0009){ref-type="ref"}. One of the key products of activated neutrophil, hydrogen peroxide, can be decomposed by bacterial hydrogenases (HPI and HPII) [10](#feb412796-bib-0010){ref-type="ref"}, [11](#feb412796-bib-0011){ref-type="ref"}, [12](#feb412796-bib-0012){ref-type="ref"}, [13](#feb412796-bib-0013){ref-type="ref"}. Unlike HPII, HPI shows not only catalase but also peroxidase activity and oxidizes *o*‐dianisidine in the presence of H~2~O~2~ [14](#feb412796-bib-0014){ref-type="ref"}, [15](#feb412796-bib-0015){ref-type="ref"}. The expression of hydrogenases is regulated by *E. coli* interaction with phagocytes and reorganization of inner and outer cell membrane [16](#feb412796-bib-0016){ref-type="ref"}.

Activation of neutrophils could depend on bacterial properties such as hydrophobicity and surface charge of bacterial cell membranes [17](#feb412796-bib-0017){ref-type="ref"}, [18](#feb412796-bib-0018){ref-type="ref"}, and expression of mannose*‐*sensitive adhesins [19](#feb412796-bib-0019){ref-type="ref"}, [20](#feb412796-bib-0020){ref-type="ref"}, [21](#feb412796-bib-0021){ref-type="ref"} and of ligands for Toll‐4 receptor of neutrophils [22](#feb412796-bib-0022){ref-type="ref"}. The hydrophobicity of bacterial cell envelope can be detected by the affinity of *E. coli* for the fluorescent membrane probes. One of them, amphiphilic 1‐anilino‐8‐naphthalenesulfonate (ANS) [23](#feb412796-bib-0023){ref-type="ref"}, does not penetrate the bacterial cell [24](#feb412796-bib-0024){ref-type="ref"} because of its negatively charged sulfo group. Another fluorescent probe used in this study, 4‐dimethylaminochalcone (DMC), is neutral and also sensitive to the hydrophobic sites on bacterial cell surface [25](#feb412796-bib-0025){ref-type="ref"}.

The aim of our work was to study the interplay of adaptive mechanisms based on peroxidase/catalase activity, surface hydrophobicity, and neutrophil‐stimulating capacity of *E. coli* from the inflamed gut. Whole blood of healthy donors was used in CL assays of ROS/RHS production in order to exclude effects of patients' immune status. We previously demonstrated that *E. coli* isolates from the healthy or inflamed human intestine were able to induce CL response in neutrophils in these conditions [26](#feb412796-bib-0026){ref-type="ref"}.

Materials and methods {#feb412796-sec-0002}
=====================

Chemicals {#feb412796-sec-0003}
---------

Lysogeny broth (LB) medium, Krebs--Ringer bicarbonate (KRB) buffer with CaCl~2~, pH 7.4, phorbol 12‐myristate 13‐acetate (PMA), *o*‐dianisidine, luminol, lucigenin, horseradish peroxidase (HRP), hydrogen peroxide (H~2~O~2~) solution (30 wt, %), potassium iodide (KI), 1‐anilino‐8‐naphthalenesulfonate (ANS), and phosphate‐buffered saline, pH 7.4 (PBS), were purchased from Sigma‐Aldrich (St. Louis, MO, USA). A working solution of H~2~O~2~ was prepared immediately before use by diluting the stock with PBS. Its concentration was controlled by measuring the absorbance at 240 nm (molar extinction coefficient of 43.6 m^−1^·cm^−1^ [27](#feb412796-bib-0027){ref-type="ref"}), HCl, and H~3~PO~4~. Tris and NaCl were from Chimmed, Russia. 4‐(Dimethylamino)chalcone (DMC) was kindly provided by Krasowitsky B.M. (Institute of Monocrystals, Kharkov, Ukraine).

Patients {#feb412796-sec-0004}
--------

Crohn's patient donors of ileum content, biopsy, or feces (*n* = 7, 5 male, two female, age 23--47, median 33), healthy feces donors (*n* = 4, 3 male, one female, age 19--28, median 19.5), and healthy blood donors (*n* = 5, female, age 21--64, median 38) were enrolled in the study and gave written informed consent (Table [1](#feb412796-tbl-0001){ref-type="table"}). For one person (male, age 14), the informed content was given by legal representatives.

###### 

Parameters of *Escherichia coli* isolates. CD patients and non‐IBD donors of feces and blood used in the study.

<table><thead><tr class="header"><th> </th><th>Patient</th><th>Isolate</th><th>CL max, Lum, LB</th><th>Px, μmol·g<sup>−1</sup> dry weight</th><th>Cat, nmol H<sub>2</sub>O<sub>2</sub>·g<sup>−1</sup> dry weight</th><th>Groups of the isolates according to their CL‐stimulating capacity</th><th><p><em>Escherichia coli</em> genome</p><p><a href="#feb412796-bib-0029" data-ref-type="ref">29</a></p></th><th><em>Escherichia coli</em> phylogroup <a href="#feb412796-note-0005" data-ref-type="fn">b</a> <a href="#feb412796-bib-0029" data-ref-type="ref">29</a></th><th>F (ANS). a.u.</th><th>F (DMC). a.u.</th><th>Localization <a href="#feb412796-bib-0030" data-ref-type="ref">30</a></th><th>Clinical activity <a href="#feb412796-bib-0030" data-ref-type="ref">30</a></th><th>Endoscopic activity <a href="#feb412796-bib-0031" data-ref-type="ref">31</a></th><th>Type of material for preparation of isolates</th><th><em>E. coli</em> DNA copies per ml aspirate/feces<a href="#feb412796-note-0004" data-ref-type="fn">a</a></th><th></th></tr></thead><tbody><tr class="odd"><td><em>E. coli</em> donors</td><td>CD</td><td>G</td><td>G</td><td>24 ± 7</td><td>36 ± 1.8</td><td>77.0 ± 4.1</td><td>2</td><td>RCE05‐01</td><td>D</td><td>32.8</td><td>26.2</td><td>Ileitis–jejunitis</td><td>Severe disease</td><td>9</td><td>Feces</td><td><p>2.1 x 10<sup>9</sup></p><p>stool</p></td></tr><tr class="even"><td>A</td><td>A1</td><td>2.5 ± 1</td><td>51.89 ± 3.2</td><td>108.4 ± 5</td><td>1</td><td>RCE01‐05</td><td>A</td><td>41 ± 6</td><td>105 ± 9</td><td>Ileitis</td><td>Mild disease</td><td>10</td><td>Lumen</td><td><p>1.25 x 10<sup>7</sup></p><p>stool</p></td><td></td><td></td></tr><tr class="odd"><td>A2</td><td>3 ± 1.2</td><td>59.9 ± 2.5</td><td>60.8 ± 4.1</td><td>1</td><td>RCE01‐02</td><td>A</td><td>Ileum biopsy</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>A3</td><td>2.8 ± 1.5</td><td>86.4 ± 3.3</td><td>86.9 ± 5</td><td>1</td><td>RCE01‐06</td><td>A</td><td>Feces</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>A4</td><td>3.5 ± 1.3</td><td>51.0 ± 2.1</td><td>24.4 ± 3.7</td><td>1</td><td>RCE01‐04</td><td>A</td><td>Lumen</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>B</td><td>B1</td><td>42.3 ± 12</td><td>28.7 ± 3</td><td>16.7 ± 2</td><td>3</td><td>RCE03‐01</td><td>D</td><td>24 ± 3</td><td>5 ± 3</td><td>Ileocolitis</td><td>Moderate disease</td><td>14</td><td>Ileum biopsy</td><td><p>2.8 x 10<sup>5</sup></p><p>aspirate</p></td><td></td><td></td></tr><tr class="odd"><td>B2</td><td>61.2 ± 10</td><td>22.1 ± 2</td><td>14.4 ± 3.2</td><td>3</td><td>RCE03‐02</td><td>D</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>M</td><td>M1</td><td>14 ± 6</td><td>33.7 ± 3.4</td><td>14.4 ± 1.6</td><td>1</td><td>RCE06‐01</td><td>B2</td><td>30 ± 6</td><td>85 ± 12</td><td>Ileocolitis</td><td>Mild disease</td><td>15</td><td>Lumen</td><td><p>2 x 10<sup>5</sup></p><p>aspirate</p></td><td></td><td></td></tr><tr class="odd"><td>M2</td><td>18 ± 6</td><td>30.0 ± 1.8</td><td>8.3 ± 2.1</td><td>1</td><td>RCE06‐02</td><td>B2</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>M3</td><td>11.8 ± 5</td><td>73.8 ± 2.2</td><td>33.8 ± 3.7</td><td>2</td><td>RCE06‐03</td><td>B2</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>M4</td><td>8 ± 3</td><td>43.7 ± 2.5</td><td>13.1 ± 2.4</td><td>2</td><td>RCE06‐04</td><td>B2</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>M5</td><td>3.2 ± 2</td><td>39.7 ± 3.3</td><td>11.5 ± 3.5</td><td>2</td><td>RCE06‐05</td><td>B2</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>Z</td><td>Z</td><td>31 ± 6</td><td>20.8 ± 2.8</td><td>78.6 ± 5</td><td>3</td><td>RCE07‐01</td><td>A</td><td>20.2</td><td>25.5</td><td>Ileocolitis</td><td>Remission</td><td>3</td><td>Lumen</td><td><p>1.3 x 10<sup>8</sup></p><p>aspirate</p></td><td></td><td></td></tr><tr class="even"><td>V</td><td>V1</td><td>9 ± 2.7</td><td>20.1 ± 2.4</td><td>273.1 ± 3</td><td>1</td><td>RCE02‐02</td><td>B1</td><td>21 ± 5</td><td>36 ± 8</td><td>Ileocolitis</td><td>Mild disease</td><td>13</td><td>Lumen</td><td><p>5 x 10<sup>4</sup></p><p>aspirate</p></td><td></td><td></td></tr><tr class="odd"><td>V2</td><td>41.8 ± 14</td><td>26.7 ± 1.8</td><td>175.8 ± 12</td><td>2</td><td>RCE02‐01</td><td>B1</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>V3</td><td>15.1 ± 4</td><td>25.8 ± 3.5</td><td>150.3 ± 8.1</td><td>2</td><td>‐</td><td>‐</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>V4</td><td>17.6 ± 4</td><td>38.0 ± 3.2</td><td>158.1 ± 6.3</td><td>3</td><td>RCE02‐03</td><td>B1</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>P</td><td>P1</td><td>18.7 ± 5</td><td>18.8 ± 2.6</td><td>105.5 ± 15</td><td>1</td><td>RCE04‐01</td><td>A</td><td>35 ± 15</td><td>33 ± 9</td><td>Ileocolitis–perianal</td><td>Severe disease</td><td>0</td><td>Lumen</td><td><p>5.2 x 10<sup>4</sup></p><p>aspirate</p></td><td></td><td></td></tr><tr class="odd"><td>P2</td><td>12.2 ± 5</td><td>40.9 ± 3.6</td><td>130.0 ± 3.5</td><td>1</td><td>RCE04‐02</td><td>A</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>P3</td><td>7.2 ± 3</td><td>45.5 ± 2.8</td><td>170.4 ± 8</td><td>2</td><td>RCE04‐03</td><td>A</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>P4</td><td>9.7 ± 3</td><td>45.5 ± 3.6</td><td>180.0 ± 10</td><td>2</td><td>RCE04‐04</td><td>A</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>P5</td><td>20.4 ± 8</td><td>24.7 ± 3</td><td>125.1 ± 8</td><td>2</td><td>RCE04‐05</td><td>A</td><td>Ileum biopsy</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>P6</td><td>10.5 ± 5</td><td>32.9 ± 2.7</td><td>130.1 ± 7</td><td>2</td><td>RCE04‐06</td><td>A</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>Healthy</td><td>C</td><td>C</td><td>59 ± 13</td><td>3.2 ± 0.7</td><td>29.1 ± 0.6</td><td>3</td><td> </td><td>15</td><td>16</td><td> </td><td>No IBD</td><td>0</td><td>Lumen</td><td><p>4 x 10<sup>2</sup></p><p>aspirate</p></td><td></td><td></td></tr><tr class="odd"><td>h‐1</td><td>H1</td><td>41.6 ± 5</td><td> </td><td> </td><td> </td><td> </td><td>No IBD</td><td> </td><td>Feces</td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>h‐2</td><td>H2</td><td>10 ± 3.2</td><td> </td><td> </td><td> </td><td> </td><td>No IBD</td><td> </td><td>Feces</td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>h‐3</td><td>H3</td><td>58.5 ± 5.1</td><td> </td><td> </td><td> </td><td> </td><td>No IBD</td><td> </td><td>Feces</td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>h‐4</td><td>H4</td><td>5 ± 2.1</td><td> </td><td> </td><td> </td><td> </td><td>No IBD</td><td> </td><td>Feces</td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>Blood donors</td><td>Blood donor 1</td><td> </td><td>No IBD</td><td> </td><td> </td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>Blood donor 2</td><td> </td><td>No IBD</td><td> </td><td> </td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>Blood donor 3</td><td> </td><td>No IBD</td><td> </td><td> </td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="even"><td>Blood donor 4</td><td> </td><td>No IBD</td><td> </td><td> </td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr class="odd"><td>Blood donor 5</td><td> </td><td>No IBD</td><td> </td><td> </td><td> </td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr></tbody></table>

Values are given as M ± SD, where M is mean value between the isolates from one patient. SD---standard deviation.

References to the genomes of *E. coli* isolates are given according to Ref. [29](#feb412796-bib-0029){ref-type="ref"}

Localization, clinical activity, and endoscopical activity of inflammation were determined according to Ref. [30](#feb412796-bib-0030){ref-type="ref"}, [31](#feb412796-bib-0031){ref-type="ref"}

The amount of *E. coli* DNA was measured in feces or aspirate even if some *E. coli* strains for study were sampled from biopsy. From CD samples, only those with *E. coli* DNA content 1 × 10^4^ copies per ml and above were selected for the study

Phylogroups of *E. coli* isolates were determined from their genomes (sequencing performed in our previous work [29](#feb412796-bib-0029){ref-type="ref"}).

John Wiley & Sons, Ltd

The inclusion criteria for CD patients were endoscopically and radiologically diagnosed, and histologically confirmed Crohn's disease and the content of *E. coli* DNA in the lumen liquid or feces above 1 × 10^4^ copies per mL. The exclusion criteria were signs of indeterminate colitis, infectious diseases, anamnesis of total colectomy, presence of stoma, and recent (less than 2 months) antibiotic treatment. The inclusion criteria for healthy individuals donating blood or feces were no intestinal or autoimmune diseases in anamnesis, no infection diseases, and no recent antibiotic treatment.

Small intestine aspirates and bowel biopsies were obtained during diagnostic endoscopy procedures, which aim was to confirm the IBD diagnosis or to evaluate the state of relapse or remission. For one person (patient C), the diagnostic endoscopy revealed no signs of IBD/inflammation; therefore, this patient was referred as 'healthy' in regard to IBD. Stool samples were collected prior to endoscopy for those subjected to it and as a morning stool sampling procedure for healthy volunteers---donors of feces. Samples were stored in sterile containers at +4 °C for up to several hours prior to *E. coli* isolation.

Blood samples from healthy volunteers were obtained by venipuncture using heparin as an anticoagulant. Blood was used for experiments immediately after the draw.

The study methodologies were conformed to the standards set by the Declaration of Helsinki and approved by Ethics committees of Federal Research and Clinical Center of Physical‐Chemical Medicine of FMBA and Moscow Clinical Scientific Center, Central Scientific Institute of Gastroenterology.

*Escherichia coli* concentration measurement {#feb412796-sec-0005}
--------------------------------------------

*Escherichia coli* concentration in ileal and fecal microbiota samples from patients was estimated using SEPTOSKRIN Kit OneStep Strip (Lytech, Moscow, Russia) according to the manufacturer's protocol. Total DNA from samples was isolated according to CTAB DNA extraction protocol described by Ref. [28](#feb412796-bib-0028){ref-type="ref"} with some modifications: 0.5 mL of material was suspended in 0.5 mL CTAB Buffer, incubated at 60 °C for 30 min, and mixed with 0.5 mL of chloroform. After centrifugation (9000 ***g***, 10 min at 4 °C), the aqueous phase was mixed with an equal volume isopropanol and 0.1 volume 3M NaOAc, pH 5.2, and placed on −20 °C for 1 h. DNA was collected by centrifugation (10 000 ***g*** for 10 min), washed with cold 80% ethanol, and resuspended in 0.2 mL of H~2~O. Total DNA concentration was measured using NanoDrop ND‐100 (Thermo Fisher Scientific, Waltham, MA, USA) and equalized to 200 ng·µL^−1^. *Escherichia coli* DNA amount in the samples was detected by quantity RT‐PCR with specific primers provided by SEPTOSKRIN Kit (Lytech).

Only CD samples with *E. coli* DNA content of 1 x 10^4^ copies per ml of initial sample and above were selected for downstream experiments.

Bacterial isolates {#feb412796-sec-0006}
------------------

*Escherichia coli* isolates were achieved as described in Ref. [29](#feb412796-bib-0029){ref-type="ref"}. Briefly, aspirates and feces were diluted by 10^6^ in sterile PBS; biopsy fragments were shaken in 0.2 mL of sterile PBS. Aliquots (100 µL) of the resulting liquid were plated on Petri dishes coated with LB agar and incubated overnight at 37 °C. The species affiliation was determined with matrix‐assisted laser desorption/ionization (MALDI) using a mass spectrometer Bruker Microflex combined with the software Biotyper from Bruker Daltonics, Germany.

Preparation of bacterial cell suspension {#feb412796-sec-0007}
----------------------------------------

*Escherichia coli* cultures were grown on an orbital shaker (150 rpm) at 37 °C by inoculating isolated colony of bacteria into LB medium. Overnight culture of bacteria was collected by centrifugation (3500 ***g***, 10 min) and washed twice with PBS. The washed cells were suspended in PBS, and their optical density (OD) at 540 nm was measured. To estimate the dry weight (DW, mg·mL^−1^), bacterial suspensions were washed with distilled water and dried. The OD of 1.0 corresponded to DW of 0.16 ± 0.03 mg·mL^−1^. Bacterial pellets were stored at −80 °C.

Adhesion and invasion assay {#feb412796-sec-0008}
---------------------------

The assay was performed according to Ref. [32](#feb412796-bib-0032){ref-type="ref"} with slight alterations. Isolates were cultivated on LB (37 °C, 200 RPM) till mid‐log phase. Bacteria were harvested by centrifugation (3500 ***g***, 15 min), and the pellet was washed with PBS and resuspended in PBS. Bacterial suspension (150 μL, OD at 540 = 0.2) was mixed with 5 mL DMEM + 20% fetal bovine serum (FBS). Bacteria in DMEM + FBS (500 μL) were added to CaCo cells grown in 24‐well plate till the monolayer formation (about 500 000 CaCo cells per well). Control bacteria suspension was collected at this point and plated onto LB agar plates at 10^−3^--10^−4^ dilution (control value). The 24‐well plates with CaCo and bacteria were incubated for 3 h at 37 °C. For invasion test, cell suspension was additionally treated with 1 mL of DMEM (20% FBS) with 300 mg·L^−1^ of gentamicin for 1 h at 37 °C. After incubation, the monolayer was gently washed twice with PBS to remove unbound bacteria and cells were removed from the plate by trypsin (200 μL). Cells were lysed by mixing with 0.5% Triton X‐100 in DMEM (20% FBS). The lysates were plated on LB agar at 10^−2^--10^−3^ dilution (5 μL per agar plate). After 24 h of incubation at 37 °C, colony counts were performed to determine colony‐forming units (CFU). Adhesion + invasion values were determined as:the number of bacteria adhered--invaded per CaCo cell = CFU per agar plate after adhesion\*dilution/500 000 (the number of CaCo cells per well);% of adhered--invaded bacteria in bacterial suspension = CFU per agar plate after adhesion/CFU per agar plate in control \* 100 (considering corresponding dilutions);Invasion value was determined as % of adhered--invaded bacteria surviving gentamicin treatment.

Chemiluminescence measurements of neutrophil activation {#feb412796-sec-0009}
-------------------------------------------------------

Chemiluminescence measurements were performed using a luminometer LKB Wallac 1251 according to the method described by Ref. [33](#feb412796-bib-0033){ref-type="ref"} with modifications [26](#feb412796-bib-0026){ref-type="ref"}. Chemiluminescence was tracked at 37 °C under continuous agitation of a sample, 20 μL of healthy volunteer's blood and 1 mL of 0.2 m[m]{.smallcaps} luminol or lucigenin in KRB solution (pH 7.4) were placed into a luminometer cuvette, and spontaneous chemiluminescence was continuously recorded for one minute. Then, a bacterial suspension in PBS was added to a final concentration of 70 ± 10 μg DW·mL^−1^ (bacteria:neutrophil cell ratio was 4000 CFU/cell), and a chemiluminescence response was recorded. Results were expressed in voltage values (mV) corresponding to maximum CL levels. The responses of donors' blood to standard activators PMA (100 n[m]{.smallcaps}) and opsonized zymosan (0.2 mg·mL^−1^) were 35 ± 19 mV and 80 ± 15 mV, respectively.

To rule out the possible toxic effects of *E. coli* on neutrophils, in a number of experiments, 156 n[m]{.smallcaps} PMA was added to the luminometer cuvette at the end of CL analysis, cuvette after the level of *E. coli*‐induced CL had reached its maximum value.

Extracellular bacterial peroxidase activity {#feb412796-sec-0010}
-------------------------------------------

Extracellular bacterial peroxidase activity was estimated by the oxidation of *o*‐dianisidine by bacterial cells in the presence of H~2~O~2~, by method described in Ref. [14](#feb412796-bib-0014){ref-type="ref"} with modifications according to Ref. [34](#feb412796-bib-0034){ref-type="ref"}. Two hundred microlitre of 100 m[m]{.smallcaps} citrate buffer (pH 5.5) containing 0.32 m[m]{.smallcaps} *o*‐dianisidine and 2.3 m[m]{.smallcaps} H~2~O~2~ was added to 200 μL of bacterial suspension (3 mg of DW per ml in PBS), and the reaction mixture was incubated for 5 min at ambient temperature. The reaction was stopped by addition of 1 mL of 35% phosphorous acid. The cells were precipitated by centrifugation at 900 g for 20 min, and the OD of supernatants was read at 560 nm. The control probes contained PBS instead of bacterial suspension. The concentration of oxidized *o*‐dianisidine was calculated by using its molar extinction coefficient of 20.040 [m]{.smallcaps} ^−1^·cm^−1^ [34](#feb412796-bib-0034){ref-type="ref"}. The amount of oxidized *o*‐dianisidine was normalized to a dry‐weight basis. To make sure that the bacterial peroxidase activity is related to the cell wall, bacterial suspensions were incubated with 1% Triton X‐100 for 1 h, and then, the cells were precipitated at 900 ***g*** (30 min), and peroxidase activity was measured in supernatant.

Bacterial catalase activity {#feb412796-sec-0011}
---------------------------

Extracellular bacterial catalase activity was measured by iodometric determination of H~2~O~2~ decomposed by bacterial cells as described in Ref. [35](#feb412796-bib-0035){ref-type="ref"}, with modifications. The assay was carried out as follows: 400 μL of cell suspension (or 400 μL of PBS in control probe) was mixed with 100 μL of 51 m[m]{.smallcaps} H~2~O~2~ solution in PBS and allowed to stand for 10 min at ambient temperature. For each *E. coli* sample, three dilutions in PBS (up to OD of 0.15, 0.30, and 0.60 at 540 nm) were used; the consumption of H~2~O~2~ by bacteria and the suspension optical density were directly proportional. Then, 20 μL of 6 N HCl and 500 μL of 245 m[m]{.smallcaps} solution of KI in H~2~O were added. Low pH provided the reaction of KI with H~2~O~2~ and inhibition of catalase activity. After 15 min of centrifugation at 600 ***g***, the OD of supernatants was read at 492 nm [35](#feb412796-bib-0035){ref-type="ref"}. The difference between the OD at 492 nm in the control (5 m[m]{.smallcaps} H~2~O~2~) and in the test probes was expressed in μmoles of H~2~O~2~ and normalized to the dry‐weight value.

Fluorescence study of the hydrophobicity of cell envelope {#feb412796-sec-0012}
---------------------------------------------------------

The measurements of fluorescence (F) were performed according to Ref. [24](#feb412796-bib-0024){ref-type="ref"} using a Hitachi F‐4000 fluorescence spectrophotometer and a 0.5 × 0.5 cm quartz cuvette. Fluorescence spectra of ANS (60 µ[m]{.smallcaps}) and DMC (30 µ[m]{.smallcaps}) were recorded at excitation wavelength of 360 nm and 420 nm, respectively. PBS or bacterial suspension was mixed with ANS or DMC before analysis; the final concentration of bacterial suspension was 0.8 ± 0.1 mg of DW·mL^−1^. The maximum fluorescence intensity was normalized to a dry‐weight basis.

To study the influence of the ionic strength of solution on the interaction between the fluorescent probes and bacteria, fluorescence intensity of the bound probe was measured twice in each sample: at the ionic strength of 0.157 [m]{.smallcaps} and 0.407 [m]{.smallcaps}. The ionic strength of the solution was increased by addition of 0.25 [m]{.smallcaps} NaCl to the mixture of the probes and bacterial cells in 0.01 [m]{.smallcaps} PBS. The ratio F(0.407)/F(0.157) was calculated, where F(0.157) and F(0.407) are the fluorescence intensity of the probe at the solution′s ionic strength of 0.157 [m]{.smallcaps} and 0.407 [m]{.smallcaps}, respectively [25](#feb412796-bib-0025){ref-type="ref"}. For negatively charged probe, ANS F(0.407)/F(0.157) \>1 indicated negatively charged surface and F(0.407)/F(0.157) \<1 suggested positively charged surface. DMC fluorescence was not expected to depend on the ionic strength of buffer solution since its molecule is uncharged.

Microscopic study {#feb412796-sec-0013}
-----------------

Morphological changes in neutrophils in blood incubated with bacteria at a 1:6 ratio of neutrophils to bacteria were examined by light microscopy according to Ref. [36](#feb412796-bib-0036){ref-type="ref"}. About 3 μL of *E. coli* suspension in PBS (OD at 540 = 2.5) was mixed with 17 μL of a healthy volunteer's blood. Incubation continued for 1 h at 37 °C with periodical shaking, and then, the smears were prepared. The smears were stained by the Romanowsky--Giemsa technique, and microscopic examination of stained cells was carried out using a Motic B3 light microscope.

Statistics {#feb412796-sec-0014}
----------

The data are shown as a mean value ± standard deviation if not indicated otherwise. Correlations were calculated by the Pearson method; for nonlinear relations, Pearson's approximation method was applied. The software [statistica]{.smallcaps} 6.0 was used for statistical analysis of data (Mann--Whitney *U*‐test or Student's *t*‐test).

Results {#feb412796-sec-0015}
=======

CL analysis of neutrophil‐stimulating capacity and hydroperoxidase activity of *Escherichia coli* {#feb412796-sec-0016}
-------------------------------------------------------------------------------------------------

Neutrophil CL was activated by bacterial suspensions in diluted blood of healthy volunteers, without leukocyte isolation [37](#feb412796-bib-0037){ref-type="ref"} in order to imitate *in vivo* conditions. CL responses varied for different isolates from 2 to 70 mV (Fig. [1](#feb412796-fig-0001){ref-type="fig"}, Table [1](#feb412796-tbl-0001){ref-type="table"}). Isolates collected from the same patient differed in CL‐stimulating capacity by 1.5--5 times, and for some patients (M, V, and P), the difference was significant. The difference between isolates did not depend on blood sample used for analysis and was reproducible for at least three batches of each isolate. No significant difference in CL was detected between isolates from CD patients (23 isolates) vs healthy individuals (five isolates) (Fig. [1](#feb412796-fig-0001){ref-type="fig"}, Table [1](#feb412796-tbl-0001){ref-type="table"}).

![Chemiluminescence responses of neutrophils stimulated by *E. coli* isolates from CD (in blue) and healthy patients (in green) in whole blood of healthy volunteers. Each point represents CL maximum value for one *E. coli* isolate averaged for 3--5 independent experiments with 3--5 different blood samples. \*Indicates patients with a significant difference between CL values of isolates within patient, *P* \< 0.05 (Student's *t*‐test).](FEB4-10-414-g001){#feb412796-fig-0001}

Since bacterial toxins can influence neutrophil activity [38](#feb412796-bib-0038){ref-type="ref"}, isolates were tested for their ability to inhibit CL response induced in diluted blood. Phorbol ester (PMA) was added to the luminometer cuvette at the end of CL analysis, when the maximum value of CL induced by *E. coli* was achieved, and the second CL maximum was registered (Fig. [2](#feb412796-fig-0002){ref-type="fig"}). No significant effect of *E. coli* on subsequent PMA‐stimulated CL response was found, so the difference between the isolates could not result from any toxic effect of bacteria toward neutrophils.

![Time development and phorbol ester (PMA) stimulation effect on CL responses of blood neutrophils stimulated by *E. coli*. Typical time curves for PBS and isolates with low (A3) and high (C) CL values are shown, moments of stimulant addition indicated by arrows. Error bars represent SD.](FEB4-10-414-g002){#feb412796-fig-0002}

Luminol‐enhanced CL stimulated in blood by *E. coli* isolates correlated with lucigenin‐enhanced CL, which is sensitive only to superoxide anion production (Fig. [3](#feb412796-fig-0003){ref-type="fig"}). Therefore, *E. coli* isolates that did not induce CL response in neutrophils probably managed it by disruption of superoxide produced by neutrophils.

![Correlation between luminol and lucigenin‐enhanced chemiluminescence of neutrophils stimulated by *E. coli* isolates from CD patients (*n* = 12). Luminol‐enhanced CL response of neutrophils in whole blood (CL (lum)) is plotted versus superoxide‐sensitive lucigenin‐enhanced CL (luc). Correlations were calculated by the Pearson method (*r* = 0.8, *P* \< 0.05, *n* = 12).](FEB4-10-414-g003){#feb412796-fig-0003}

In order to evaluate the ability of bacteria to protect themselves from ROS produced by neutrophils, catalase and peroxidase activities of *E. coli* isolates were assessed without cell destruction. Less than 10% of extracellular peroxidase activity was solubilized by Triton X‐100, indicating that the major part of enzymes was cell wall‐bound (tested for 12 *E. coli* isolates, data not shown).

We found that *E. coli* isolates with the highest peroxidase activity induced low CL response, while the isolates with significant CL‐stimulating capacity showed the lowest peroxidase activity, and this negative correlation was significant (*P* \< 0.05; Fig. [4](#feb412796-fig-0004){ref-type="fig"}). There was no isolate combining high peroxidase‐ and CL‐stimulating activities. Bacterial catalase activity showed the same tendency, but correlation between catalase activity and CL values was not significant.

![Correlation between CL response of whole blood neutrophils to *E. coli* isolates and their peroxidase activity. Peroxidase activity (Px) is given in µmol of oxidized o‐dianisidine per g of bacterial pellet dry weight. Significance (*P*) was quantified by the Pearson method for nonlinear correlation (*t* ~0.5~ = 2.05). Values for isolates C, A3, and V1 (analyzed in microscopic assay with neutrophils below) are indicated by black diamonds.](FEB4-10-414-g004){#feb412796-fig-0004}

Since luminol‐enhanced CL depends on H~2~O~2~ and H~2~O~2~‐derived HOCl [9](#feb412796-bib-0009){ref-type="ref"}, the direct effect of peroxidase activity on CL should be evaluated. Exogenous peroxidase (HRP) was added to the CL probes with isolate C (with the lowest peroxidase activity of its own; Table [1](#feb412796-tbl-0001){ref-type="table"}) so that its activity was equal to the highest demonstrated by *E. coli* isolates in the current study (86.4 ± 3.3 µmol·g^−1^ dry weight; Table [1](#feb412796-tbl-0001){ref-type="table"}). This did not affect CL response of blood neutrophils, suggesting that the low CL response is not due to chemiluminescence inhibition by ROS eliminating.

Morphological analysis of neutrophil activation {#feb412796-sec-0017}
-----------------------------------------------

Microscopic study of morphological alterations of stimulated neutrophils was performed to detect whether there are other signs of activation induced in neutrophils by *E. coli* isolates with low CL‐inducing activity. As such, two CD isolates with low CL activity were selected---A3 and V1. Isolate C (from healthy patient) was selected as a control isolate with the one of the highest neutrophil‐stimulating activities (regarding CL response induction).

Figure [5](#feb412796-fig-0005){ref-type="fig"} demonstrates that all isolates induced signs of neutrophil activation: swelling of neutrophils nuclei, formation of vacuoles, and cell aggregation (Fig. [5](#feb412796-fig-0005){ref-type="fig"}A).

![Effect of *E. coli* isolates with diverse CL‐stimulating activity on the morphological features of neutrophils. Whole blood samples were incubated with *E. coli* isolates that have induced low (A3 and V1) and high (C) CL response. The Romanowsky--Giemsa staining was used to visualize the details. At least 50 microscope fields of view per isolate were evaluated for picture and calculations. (A) Typical picture of activated neutrophil for each isolate: 1---*E. coli* cells; 2---neutrophils/neutrophil aggregates containing vacuoles (arrows indicate the captured bacterial cells); 3---platelets, 4---erythrocytes; 5---eosinophil; and 6---monocyte with captured bacteria. The length of the scale bars is 20 μm. (B) Parameters of phagocytic activity of neutrophils stimulated by *E. coli* isolates. Mean values are given ± SD.](FEB4-10-414-g005){#feb412796-fig-0005}

Isolate with the lowest CL‐stimulating activity (A3) was the least susceptible to the phagocytosis (Fig. [5](#feb412796-fig-0005){ref-type="fig"}B), even though the neutrophils incubated with it showed signs of activation. Only the cells of isolate with the highest CL‐stimulating activity (C) showed signs of degradation in phagolysosome (the engulfed bacterial cells differ in form and staining from the free ones). This isolate also induced higher number of vacuoles formed within neutrophil cells. As for the isolate V, the vacuoles with bacteria were rather phagosomes, smaller than for isolate C, and with no signs of bacterial digestion.

Fluorescent analysis of hydrophobicity of *Escherichia coli*cell surface {#feb412796-sec-0018}
------------------------------------------------------------------------

As shown by the experiments above, the difference in neutrophil capturing capacity toward *E. coli* could not be entirely attributed to the activity of bacterial hydrogenases or to the direct inhibiting effect of bacteria on neutrophils. Another factor contributing in that is the possible difference in the cell surface properties of various isolates.

*Escherichia coli* cell surface properties were studied by fluorescent probes ANS (negatively charged amphiphilic) and DMC (neutral hydrophobic). Addition of bacterial suspensions significantly increased probes' fluorescence intensity: from 2.4 ± 0.3 to 16--64 a.u. for ANS and from 1.4 ± 0.1 to 2 -- 110 a.u. for DMC. The averaged values for isolates within patients are given in Table [1](#feb412796-tbl-0001){ref-type="table"}.

Binding of the probes to the bacterial surface and transition from an aquatic to a hydrophobic environment were proved by the blue shift of the fluorescence maxima [39](#feb412796-bib-0039){ref-type="ref"}, [40](#feb412796-bib-0040){ref-type="ref"}, [41](#feb412796-bib-0041){ref-type="ref"} registered for ANS (from 512 ± 1 to 490 ± 2nm) and for DMC (from 522 ± 1 nm to 499 ± 1 nm) in bacterial suspensions.

Fluorescence intensity of both probes negatively correlated with CL values: *r *= −0.46 in the experiments with ANS (data not shown) and *r *= −0.63 in the experiments with DMC, where the correlation was significant at *P* \< 0.05 (Fig. [6](#feb412796-fig-0006){ref-type="fig"}).

![Correlation between CL response of whole blood neutrophils induced by *E. coli* isolates and their DMC fluorescence intensity reflecting bacterial surface hydrophobicity. DMC hydrophobic fluorescent probe was added to 24 isolate bacterial suspensions (Table [1](#feb412796-tbl-0001){ref-type="table"}), and F(DMC) was recorded at 499 nm. Significance (*P*) was quantified by the Pearson method for nonlinear correlation (*t* ~0.5~ = 2.05).](FEB4-10-414-g006){#feb412796-fig-0006}

To establish the role of electrostatic forces in the interaction of the probes with *E. coli*, the effect of the increase in ionic strength was studied. We detected approximately 10% elevation of ANS fluorescence intensity, F(0.407)/F(0.157) = 1.07 ± 0.08. Thus, the contribution of electrostatic forces to the binding of the probe to *E. coli* was not significant. Fluorescence values in experiments with DMC were not influenced by ionic forces and therefore resulted from hydrophobic binding of the probe to the bacterial cell surface.

Analysis of the adhesive and invasive ability of *Escherichia coli* isolates {#feb412796-sec-0019}
----------------------------------------------------------------------------

Analysis of the ability of *E. coli* isolates to adhere and invade CaCo cells was performed for eight isolates from seven CD patients that demonstrated high, low, and intermediate values of neutrophil‐stimulating peroxidase and catalase activities (Table [1](#feb412796-tbl-0001){ref-type="table"}), two isolates from healthy individuals, and one laboratory strain MG1655 (Table [2](#feb412796-tbl-0002){ref-type="table"}). Higher adhesion ability (5--30 times more than the laboratory strain) was demonstrated by four isolates (V2, V4, M4, and G). Invasion was demonstrated by three isolates (V2, M4, and P2). Therefore, adhesive--invasive activity was observed for two isolates (V2 and M4).

###### 

Adhesion and invasion assay

                                                            V2            V4             M4             G              P2             A1             B1             H1             C             MG1655
  --------------------------------------------------------- ------------- -------------- -------------- -------------- -------------- -------------- -------------- -------------- ------------- ---------------
  CFU per agar plate in control ×10^4^                      19.5 ± 1.92   22.87 ± 2.23   18.13 ± 2.03   13.25 ± 1.91   55.67 ± 4.59   74.67 ± 4.03   76.17 ± 4.07   46.83 ± 4.07   50 ± 4        18.875 ± 2.53
  CFU per agar plate after adhesion. ×10^3^                 9.75 ± 1.83   18.37 ± 6.57   59.33 ± 9.09   11 ± 0.93      3.67 ± 0.82    3.5 ± 0.55     8.83 ± 1.47    1.5 ± 0.55     4.33 ± 0.82   1.9875 ± 0.23
  CFU per agar plate after gentamicin treatment             12.5 ± 4.63   0              47.5 ± 11.65   0              13.33 ± 5.16   0              41.67 ± 9.83   0              0             0
  Number of adhered--invaded bacteria per CaCo cell         0.02          0.04           0.12           0.02           0.007          0.007          0.018          0.003          0.009         0.004
  \% of adhered--invaded bacteria in bacterial suspension   5             8.03           32.74          8.3            0.66           0.47           1.16           0.32           0.87          1.05
  \% of invaded bacteria                                    0.13          0              0.08           0              0.36           0              0.47           0              0             0

Values are given ± SD (standard deviation).
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No correlation was observed between adhesive and invasive ability of *E. coli* isolates and the intensity of neutrophil stimulation (Tables [1](#feb412796-tbl-0001){ref-type="table"} and [2](#feb412796-tbl-0002){ref-type="table"}). Isolates with the lowest CL values (A1) and with the highest (C) demonstrated no adhesion and invasion activity. Isolates with maximum observed adhesive--invasive isolates demonstrated both high (V2) and low CL values (M4).

*Escherichia coli* isolates fall into three groups {#feb412796-sec-0020}
--------------------------------------------------

The isolates could be divided into three groups on the basis of their CL‐stimulating capacity: group 1 with CL values of 1−10 mV, group 2 with CL values of 11--30 mV, and group 3 with CL of more than 31 mV (Table [1](#feb412796-tbl-0001){ref-type="table"}).

As Fig. [7](#feb412796-fig-0007){ref-type="fig"} demonstrates, cell surface hydrophobicity (F(DMC)) and peroxidase activity (Px) significantly differed between these groups.

![Three groups of *E. coli* isolates. *E. coli* isolates were arranged in three groups according to the CL‐inducing activity (from the lowest to the highest, 1, 2, and 3). The following parameters were compared within/between the groups: extracellular peroxidase activity (Px, μmol·g^−1^ DW), cell surface hydrophobicity defined by probe fluorescence (F(ANS), a. u., and F(DMC), a.u.), and extracellular catalase activity (catalase, nmol·g^−1^). Significant difference is indicated: \*---in comparison with group 1; \#---in comparison with group 2 (*P* \< 0.05, Mann--Whitney test).](FEB4-10-414-g007){#feb412796-fig-0007}

These data suggest the existence of three different *E. coli* phenotypes differing in their ability to evade ROS production by neutrophils, extracellular peroxidase activity, and cell surface hydrophobicity. *Escherichia coli* isolates of the same origin can belong to different phenotypes (patients 'M', 'V', and 'P'), or to one (patient 'A' and 'B').

Parameters such as the source of isolate, the severity of disease, inflammation localization, and sex/age of patients and isolates phylogroup showed no correlation with the intensity of neutrophil stimulation or bacterial hydroperoxidase activity (Table [1](#feb412796-tbl-0001){ref-type="table"}, File S1).

Discussion {#feb412796-sec-0021}
==========

The role of *E. coli* in the acute inflammation during Crohn's disease is still disputable [42](#feb412796-bib-0042){ref-type="ref"}, [43](#feb412796-bib-0043){ref-type="ref"}, [44](#feb412796-bib-0044){ref-type="ref"}. However, multiple observations of *E. coli* intensive growth in the afflicted intestine suggest that bacteria proliferating under such conditions have to develop some mechanisms of resistance to ROS/RHS or avoiding their formation. The aim of the current study was to evaluate various isolates of *E. coli* in regard to their interaction with inflammation agents, such as neutrophils and ROS.

We have observed high variability in these parameters in *E. coli* from CD patients. In particular, a phenotype was detected combining low neutrophil activation with high ROS utilization activity. About 39% of the total number of *E. coli* isolates from CD patients (9 isolates of 23) induced CL response below 10 mV, and four of seven CD patients involved into the study had in their intestine at least one isolate with low CL‐stimulating activity. At the same time, 17.4% of CD isolates (4 out of 23) induced high CL responses and showed much lower peroxidase activity.

The low CL‐inducing isolates were not completely 'invisible' to neutrophils, as was shown by microscopic study in the experiments with the isolates A3 and V1.

It is necessary to mention that low CL values were indeed correct indications of decreased neutrophil activation, and not a result of bacterial utilization of ROS produced by activated neutrophils. This was confirmed by the fact that luminol CL values correlated with lucigenin CL independent of H~2~O~2~ production by neutrophils, and was insensitive to exogenous peroxidase (HRP [45](#feb412796-bib-0045){ref-type="ref"}). Presumably, isolates with low CL‐stimulating capacity were able to avoid the induction of ROS/RHS production at all during neutrophil activation.

Previously published researches suggested that bacterial cell surface hydrophobicity could influence the scenario of neutrophil activation, and bacteria with high hydrophobicity should have the most stimulating capacity [17](#feb412796-bib-0017){ref-type="ref"}, [18](#feb412796-bib-0018){ref-type="ref"}. Unexpectedly, in the studied *E. coli* isolates, the higher hydrophobicity corresponded to the lower CL values and the higher peroxidase activity.

Alignment of *E. coli* genome sequences from different intestine parts of one patient performed earlier [29](#feb412796-bib-0029){ref-type="ref"} revealed only minor heterogeneity and some deletions (usually a deletion of one of the smaller contigs, probably a plasmid). At the same time, sequences of genes identified as encoding catalases and peroxidases of isolates from one patient were identical, since none of the found polymorphisms was located in those genes. Therefore, one may suggest that the difference in phenotype of genetically close isolates from one patient observed in the current study (patients V, M, and P) could be due to the mobile elements of genome that could be achieved via horizontal transfer.

Hence, we report that *E. coli* isolates from CD patients are rather variable regarding the interaction with inflammation agents. One of the phenotypes observed combines the ability for low neutrophil activation with comparatively high ability to utilize extracellular ROS and increased cell surface hydrophobicity.
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**File S1.** Parameters of *E. coli* isolates are presented on 3D plot: CL (Chemiluminescent responce intensity, lum), Cat (extracellular catalase activity, nmol H~2~O~2~/ g dry weight) and Px (peroxidase activity, µmol of oxidized o‐dianisidine per g of bacterial pellet dry weight).

###### 

Click here for additional data file.
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